A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Key facts

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Intervention

TQ05105 tablets(drug)

Enrollment

52 enrolled

Eligibility

18-70 years · All sexes

Timeline

2024 – 2026

Study locations (12)

• Anhui Provincial Hospital, Hefei, Anhui, China
• The 940th hospital of joint logistics support force of Chinese people's liberation army, Lanzhou, Gansu, China
• Guangzhou First People's Hospital, Guangzhou, Guangdong, China
• The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
• The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
• Xiangyang Central Hospital, Xiangyang, Hubei, China
• Tai'an Central Hospital, Taian, Shangdong, China
• Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China
• The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shannxi, China
• Hematology Hospital of the Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China
• The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
• The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07394608
  Paired Non-invasive VNS in Adolescent Cerebral Palsy Rehabilitation
  Icahn School of Medicine at Mount Sinai
• RECRUITINGPHASE2NCT07124078
  A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
  Incyte Corporation
• RECRUITINGEARLY PHASE1NCT07355868
  Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
  Regend Therapeutics
• RECRUITINGNANCT06857929
  "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"
  IMDEA Food
• RECRUITINGPHASE1NCT07389044
  A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
  IntegerBio
• RECRUITINGNCT07127926
  Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
  M.D. Anderson Cancer Center
• RECRUITINGPHASE1NCT07138196
  A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease
  Qurient Co., Ltd.
• ACTIVE NOT RECRUITINGNCT07321080
  Central Sensitisation in Nociceptive and Neuropathic Pain
  IRCCS Centro Neurolesi Bonino Pulejo

See all trials for Chronic graft versus host disease →